Psychedelics in Focus: Clinical Trials, Transformations and Regulations, Upcoming Webinar Hosted by Xtalks
TORONTO, Nov. 8, 2023 /PRNewswire-PRWeb/ -- Join us for an informative webinar as we delve into the world of psychedelic trials and the evolving regulatory landscape surrounding these transformative therapies. Explore the promising efficacy of psychedelics like psilocybin, MDMA, 5-methoxy-dimethyltryptamine, and ibogaine in treating conditions such as depression, PTSD, anxiety, and substance use disorder.
- Attendees will explore the specific aspects of psychedelics crucial for orchestrating clinical trials.
- The featured speakers will discuss the regulatory landscape governing novel psychedelic clinical studies in Australia.
- The speakers will also delve into the outlook for emerging psychedelic compounds and their potential impact on the future.
- Discuss the important results observed in clinical trials, showcasing the potential for durable effects lasting over a year post-dosing.